Clinical Research Directory
Browse clinical research sites, groups, and studies.
Telo Genomics Technology to Detect & Profile Multiple Myeloma MRD
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Summary
The purpose : Detect and profile Multiple myeloma Measurable Residual Disease(MRD) prognostics for monitoring post-transplant Multiple Myeloma (MM) Patients receiving maintenance therapy.
Official title: Detect and Profile Multiple Myeloma Measurable Residual Disease (MRD )Prognostics for Monitoring Post-transplant Multiple Myeloma (MM) Patients Receiving Maintenance Therapy.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
70
Start Date
2024-05-01
Completion Date
2028-09
Last Updated
2025-04-03
Healthy Volunteers
No
Conditions
Interventions
Standard of care
Participants will not receive any intervention in this study. Participants will receive standard of care therapy
Locations (1)
Jewish General Hospital
Montreal, Quebec, Canada